Volume 27, Number 1—January 2021
Research
Cellular Immunity in COVID-19 Convalescents with PCR-Confirmed Infection but with Undetectable SARS-CoV-2–Specific IgG
Table
Parameter | Ratio <1.1 | Ratio 1.1–3.0 | Ratio >3.0 |
---|---|---|---|
All donors | 13 (16.7) | 24 (30.8) | 41 (52.6) |
Age, y | 45 (19–55) | 51 (28–65) | 47 (20–66) |
Sex, M/F | 6/7 | 19/5 | 29/12 |
Body mass index | 25.2 (22.3–30.1) | 24.9 (22.8–28.1) | 26.7 (22.2–36.8) |
Interval to onset of symptoms, d | 52 (32–100) | 60 (24–98) | 64 (22–112) |
Stay in risk area/risk contact |
6 |
17 |
20 |
Symptoms of COVID-19 infection | |||
Cough | 7 | 19 | 30 |
Fever | 9 | 13 | 24 |
Shortage of air | 3 | 4 | 15 |
Rhinitis | 7 | 7 | 16 |
Sore throat | 6 | 8 | 15 |
Limb pain | 7 | 15 | 19 |
Shivering | 6 | 8 | 15 |
Diarrhea | 5 | 6 | 15 |
Weight loss | 3 | 2 | 9 |
Nausea | 0 | 0 | 4 |
Loss of appetite | 5 | 3 | 12 |
Headaches | 7 | 16 | 26 |
Skin rash | 1 | 1 | 1 |
Swelling of lymph nodes | 3 | 0 | 2 |
Loss of sense of smell and taste |
8 |
16 |
18 |
Necessity of oxygen supply | 0 | 1 | 3 |
Antimicrobial treatment |
1 |
3 |
7 |
Blood group | |||
O | 5 | 12 | 16 |
A | 6 | 8 | 16 |
B | 0 | 0 | 6 |
AB | 1 | 3 | 3 |
ND | 1 | 1 | 0 |
*Values are no. donors or median (range). Ratio is IgG against the S1 protein. ND, not determined.
Page created: October 15, 2020
Page updated: December 21, 2020
Page reviewed: December 21, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.